Clicky

Windtree Therapeutics, Inc.(WINT) News

Date Title
Jul 25 Why Are Public Companies Amassing ETH, XRP, SOL, BNB Instead Of Just Bitcoin?
Jul 22 Kraken to Support Biotech Firm Windtree’s $200M BNB Treasury Play
Jul 18 BNB Rises as Binance Dominates Q2 Volumes, Windtree Unveils $200M Treasury
Jul 17 BC-Most Active Stocks
Jul 17 Biotech Company Windtree to Raise Up to $200M for BNB Treasury
Jul 16 Windtree to raise $200M to launch a BNB treasury strategy
Jul 2 Windtree Announces Issuance of Istaroxime Patent for the United States for Acute Heart Failure
Jun 30 Windtree Announces Istaroxime Phase 2 Cardiogenic Shock Study Hits Enrollment Target for Planned Interim Analysis
Jun 26 Windtree Advances Lower Cost Manufacturing of PHEXXI, Evofem’s Hormone-Free, On-Demand Prescription Contraceptive Gel
Jun 16 Windtree Announces Publication of Istaroxime Positive Phase 2 SEISMiC B Study
Apr 15 Windtree Therapeutics Reports Year-End 2024 Financial Results and Provides Key Business Updates
Feb 18 Windtree Therapeutics, Inc. Announces Reverse Stock Split
Feb 12 Windtree Announces Special Late-Breaking Clinical Science Abstract Presentation on Istaroxime at the Technology and Heart Failure Therapeutics Conference
Oct 9 Windtree Announces Publication of Positive Istaroxime Phase 2b Study Trial Design
Aug 14 Windtree Announces New Additions and Changes to Its Board of Directors
Jul 25 Windtree Therapeutics Provides Update on Istaroxime Clinical Development and Upcoming Clinical Trial Data
Apr 8 Windtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge Financing
Feb 1 Windtree Renews Agreement with Chang Gung University for Scientific Collaboration to Further SERCA2a Research
Dec 19 Istaroxime Update: Start Of Patient Dosing In Early Cardiogenic Shock SEISMiC Extension Study In Preparation For Phase 3 Readiness, Topline Data Expected Mid-2024
Dec 18 Windtree Therapeutics Announces the Start of Patient Dosing In Phase 2 SEISMiC Extension Study of Istaroxime in Early Cardiogenic Shock